General MedicationsINJECTIONGeneric
IOBENGUANE SULFATE I 131
IOBENGUANE SULFATE I-131
Standard Dose
2.3mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview IOBENGUANE SULFATE I 131 is listed in Drugs@FDA under application 020084 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient IOBENGUANE SULFATE I-131 Form and strength INJECTABLE;INJECTION - 2.3mCi/ML Sponsor PHARMALUCENCE Submission history Latest submission status date: 1999-11-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview IOBENGUANE SULFATE I 131 is listed in Drugs@FDA under application 020084 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IOBENGUANE SULFATE I-131 Form and strength INJECTABLE;INJECTION - 2.3mCi/ML Sponsor PHARMALUCENCE Submission history Latest submission status date: 1999-11-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.